These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 31789477

  • 1. Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?
    Gorges M, Kunz MS, Müller HP, Liepelt-Scarfone I, Storch A, Dodel R, Hilker-Roggendorf R, LANDSCAPE Consortium, Berg D, Kalbe E, Braak H, Del Tredici K, Baudrexel S, Huppertz HJ, Kassubek J.
    Hum Brain Mapp; 2020 Apr 15; 41(6):1416-1434. PubMed ID: 31789477
    [Abstract] [Full Text] [Related]

  • 2. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C, García-Lorenzo D, Garcia-Garcia D, Clavero P, Obeso JA, Lehericy S, Rodríguez-Oroz MC.
    Brain Imaging Behav; 2019 Feb 15; 13(1):180-188. PubMed ID: 28710667
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H, Mak E, Yong TT, Wen MC, Chander RJ, Au WL, Sitoh YY, Tan LC, Kandiah N.
    Eur J Neurol; 2017 Feb 15; 24(2):341-348. PubMed ID: 27943468
    [Abstract] [Full Text] [Related]

  • 5. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M, Canu E, Donzuso G, Stojkovic T, Basaia S, Stankovic I, Tomic A, Markovic V, Petrovic I, Stefanova E, Kostic VS, Agosta F.
    Mov Disord; 2020 Nov 15; 35(11):1987-1998. PubMed ID: 32886420
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease.
    Pereira JB, Hall S, Jalakas M, Grothe MJ, Strandberg O, Stomrud E, Westman E, van Westen D, Hansson O.
    Neurobiol Dis; 2020 Jun 15; 139():104831. PubMed ID: 32145376
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT.
    Brain; 2015 Oct 15; 138(Pt 10):2974-86. PubMed ID: 26173861
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
    Baba T, Hosokai Y, Nishio Y, Kikuchi A, Hirayama K, Suzuki K, Hasegawa T, Aoki M, Takeda A, Mori E.
    J Neurol Sci; 2017 Jan 15; 372():288-293. PubMed ID: 28017230
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cortical thinning associated with mild cognitive impairment in Parkinson's disease.
    Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Garcia-Diaz AI, Vendrell P, Bargallo N, Tolosa E, Junque C.
    Mov Disord; 2014 Oct 15; 29(12):1495-503. PubMed ID: 25100674
    [Abstract] [Full Text] [Related]

  • 14. Progressive brain atrophy in Parkinson's disease patients who convert to mild cognitive impairment.
    Zhou C, Guan XJ, Guo T, Zeng QL, Gao T, Huang PY, Xuan M, Gu QQ, Xu XJ, Zhang MM.
    CNS Neurosci Ther; 2020 Jan 15; 26(1):117-125. PubMed ID: 31278861
    [Abstract] [Full Text] [Related]

  • 15. Regional volumetric change in Parkinson's disease with cognitive decline.
    Gee M, Dukart J, Draganski B, Wayne Martin WR, Emery D, Camicioli R.
    J Neurol Sci; 2017 Feb 15; 373():88-94. PubMed ID: 28131236
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cortical thinning is associated with disease stages and dementia in Parkinson's disease.
    Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, Tolosa E, Martí MJ.
    J Neurol Neurosurg Psychiatry; 2013 Aug 15; 84(8):875-81. PubMed ID: 23463873
    [Abstract] [Full Text] [Related]

  • 20. Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease.
    Chung SJ, Park YH, Yoo HS, Lee YH, Ye BS, Sohn YH, Lee JM, Lee PH.
    Neurobiol Aging; 2019 Jun 15; 78():168-177. PubMed ID: 30947112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.